Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpe Special Opp Regulatory News (ESO)

Share Price Information for Epe Special Opp (ESO)

Share Price is delayed by 15 minutes
Get Live Data
237.00    -1.00 (-0.42%)
Bid:
232.00
Ask:
242.00
Spread: 10.00 (4.31%)
Market Cap: £58.41m
ESO Live PriceLast checked at - London Stock Exchange

Intraday Epe Special Opp Share Chart

Investment

4 Jul 2025 10:00

RNS Number : 8005P
EPE Special Opportunities Limited
04 July 2025
 

EPE Special Opportunities Limited

 

Investment

 

 

EPE Special Opportunities Limited ("ESO" or the "Company") is pleased to announce that on 2 July 2025, ESO Investments 1 Limited (an undertaking of ESO, in which it is the sole investor) ("ESO 1") acquired a majority stake in Prism Holdco (2025) Limited (the "Target" or, together with undertakings, the "Target Group") (the "Transaction").

 

The Target Group owns the LSA International brand which designs, develops and distributes a wide range of award-winning interior products, including glassware, tableware and interior accessories. The Target Group has achieved a strong reputation for design led, contemporary products centred on quality, craftmanship and sustainability. The Target Group supplies a broad range of premium retailers, hospitality partners and distributors in the UK and international markets, as well as operating e-commerce and marketplace channels. ESO will assist the Target Group's future growth ambitions, accelerated by collaboration and integration with the Company's existing portfolio company in the sector, the Rayware Group.

 

As part of the transaction, ESO 1 is investing up to £2.1 million (funded by cash reserves advanced from ESO) to fund the paydown of bank debt (£1.1 million) and to support working capital (£1.0 million), and ESO issued 298,013 shares to the former shareholders of LSA International. Following the Transaction, ESO has available cash of £7.1 million. The Transaction has no impact on the Company's net asset value.

 

Application has been made for the admission to trading on AIM of the 298,013 consideration shares which is expected to occur on 9 July 2025. Following admission, ESO will have 28,396,073 ordinary shares in issue with each ordinary share carrying the right to one vote. The total number of voting rights in the Company is therefore 28,396,073. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interests in, the Company under the FCA's Disclosure and Transparency Rules.

 

About ESO

 

· ESO is an AIM-quoted, private equity investment company, whose objective is to provide long-term return on equity for its shareholders by investing in SMEs.

 

· ESO seeks to invest up to £30 million into companies with strong fundamentals, including defensible competitive positioning and high levels of cash generation, and aims to partner with outstanding management teams to combine operational and financial expertise in each investment.

 

· ESO will consider most industry sectors, including consumer, retail, manufacturing, financial services and the broader services sectors, and can make direct investments, special situations investments, primary and secondary fund investments and private investments in public equities.

 

· ESO's investment horizon is flexible, creating the opportunity to maximise value via optimising exit timing, compounding returns and re-investing behind successful management teams.

 

The person responsible for releasing this information on behalf of the Company is Amanda Robinson of Langham Hall Fund Management (Jersey) Limited.

 

Enquiries:

 

EPIC Investment Partners LLP

+44 (0) 207 269 8860

Rupert Palmer

Langham Hall Fund Management (Jersey) Limited

+44 (0) 153 488 5200

Amanda Robinson

 

Cardew Group Limited

+44 (0) 207 930 0777

Richard Spiegelberg

 

Deutsche Numis

+44 (0) 207 260 1000

Nominated Advisor:

Stuart Skinner / Emma Brown

Corporate Broker:

Charles Farquhar

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRIMPTMTIMMFA
Date   Source Headline
10th Apr 201511:22 amRNSNet Asset Value(s)
10th Apr 20157:00 amRNSDirector/PDMR Shareholding
7th Apr 20157:00 amRNSDirector Shareholding , Share cap and share match
2nd Apr 20153:37 pmRNSHolding(s) in Company
18th Mar 20157:00 amRNSAnnual Financial Report
2nd Feb 20152:45 pmRNSInterest Payment on Convertible Loan Notes (CLN)
30th Jan 201510:24 amRNSHolding(s) in Company
29th Dec 20147:00 amRNSDisposal
7th Nov 20149:27 amRNSNet Asset Value(s)
13th Oct 201410:16 amRNSNet Asset Value(s)
22nd Sep 20147:00 amRNSHalf Yearly Report
31st Jul 201412:51 pmRNSInterest Payment on Convertible Loan Notes (CLN)
22nd Jul 20142:29 pmRNSResult of AGM
9th Jul 20148:39 amRNSNet Asset Value(s)
27th Jun 201411:56 amRNSNotice of AGM
9th Jun 201410:40 amRNSNet Asset Value(s)
9th May 201410:50 amRNSNet Asset Value(s)
8th Apr 20143:19 pmRNSNet Asset Value(s)
2nd Apr 20148:48 amRNSDirector/PDMR Shareholding and Share Matching Plan
28th Mar 201412:00 pmRNSHolding(s) in Company
18th Mar 20147:00 amRNSAnnual Financial Report
20th Feb 20147:00 amRNSDisposal
31st Jan 201410:53 amRNSInterest Payment on Convertible Loan Notes
7th Jan 201410:23 amRNSNet Asset Value(s)
9th Dec 201311:06 amRNSNet Asset Value(s)
18th Nov 20132:36 pmRNSTransaction in Own Shares
11th Nov 20132:14 pmRNSNet Asset Value(s)
9th Oct 201311:59 amRNSNet Asset Value(s)
16th Sep 20137:00 amRNSHalf Yearly Report
21st Aug 20133:12 pmRNSHolding(s) in Company
20th Aug 201310:44 amRNSCancelling of Treasury Shares
31st Jul 201310:11 amRNSInterest Payment on Convertible Loan Notes
16th Jul 20133:59 pmRNSResult of AGM
8th Jul 20133:51 pmRNSNet Asset Value(s)
4th Jul 20137:00 amRNSTransaction in Own Shares
3rd Jul 20137:00 amRNSTransaction in Own Shares
2nd Jul 201310:31 amRNSTransaction in Own Shares
1st Jul 20131:50 pmRNSTransaction in Own Shares
26th Jun 20137:00 amRNSTransaction in Own Shares
19th Jun 20137:00 amRNSNotice of AGM
11th Jun 20137:00 amRNSInvestment Update and Net Asset Value
23rd May 20132:00 pmRNSHolding(s) in Company
16th May 201310:56 amRNSNet Asset Value(s)
11th Apr 20132:09 pmRNSNet Asset Value(s)
5th Apr 20139:56 amRNSHolding(s) in Company
3rd Apr 201311:52 amRNSPosting of Annual Report & Accounts
14th Mar 20139:19 amRNSTransaction in Own Shares
13th Mar 20135:28 pmRNSTransaction in Own Shares
11th Mar 20139:00 amRNSFinal Results
28th Feb 201310:51 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.